Switch to:
GuruFocus articles
Headlines from internet
Nov-17-17$35.06 (-0.37%)
03:41PMTheravance Shares Rise on Approval of Glaxo's COPD Therapy Zacks
03:12PMNascar driver danica patrick says 'i'm not a car person' theStreet
02:16PMGlaxo's Triple Therapy COPD Inhaler Gets Marketing Nod in EU Zacks
09:31AMDaily Pharma Scoop Gilead Car T Potential Egalet Surges Aerie Launches Mid Stage Study Seekingalpha
Nov-15-17$34.88 (-0.29%)
08:47AMAstraZeneca's (AZN) Asthma Drug Benralizumab Approved by FDA Zacks
07:00AMWall Street Breakfast Order War Dubai Airshow Seekingalpha
Nov-14-17$34.98 (-0.31%)
08:25PMGlaxo Pfizer Top Safer Dividend Healthcare Gainers November Seekingalpha
02:02PMHealthcare Dogfight Glaxosmithkline Regains Top Gains November O And M And Patterson Close Seekingalpha
12:14PMDaily Pharma Scoop Heron Undervalued Theravance Submits Nda Nektar Continues Surge Seekingalpha
08:48AMGlaxo's Subcutaneous Formulation of Benlysta Approved in EU Zacks
07:23AMIt's Not Too Late to Buy Dynavax Stock After Its Hepatitis B Vaccine Approval Fool
Nov-10-17$35.3 (-1.31%)
11:05AM2 High Quality U K Dividend Stocks Portfolio Seekingalpha
08:03AMPharma Stock Roundup: AstraZeneca's Q3 Earnings, Roche & Merck Drugs Get FDA Nod Zacks
01:57AMDynvax Reaches Final Point Journey Fda Approval Achieved Hepatitis B Vaccine Seekingalpha
Nov-09-17$35.77 (-1.95%)
12:07PMMovements Top Glaxosmithkline Seekingalpha
Nov-08-17$36.48 (+1.84%)
02:48PMNew Contracts and Products Help Emergent BioSolutions Inc Get It Done Fool
10:39AMHere's What Cost GlaxoSmithKline PLC Nearly $10 Billion in Market Cap in October Fool
Nov-07-17$35.82 (-0.89%)
12:01PMDaily Pharma Scoop Anxious Time Dynavax Longs Vbl Therapeutics Gets Boost Roche Gets 2 Fda Seekingalpha
10:18AMDynavaxs Binary Moment Seekingalpha
07:33AM3 International Stocks for Retirees Fool
Nov-06-17$36.14 (-0.03%)
06:21PMGlaxo vs Gilead: Put Up Your Dukes? Barron's
12:43PMGlaxo vs Gilead: Put ‘Em Up? Barron's
11:04AMMylan (MYL) Misses on Earnings and Sales Estimates in Q3 Zacks
09:47AMDynavax Reaches Finish Line Triumph Stumble Seekingalpha
04:50AMTracking Kahn Brothers Portfolio Q3 2017 Update Seekingalpha
Nov-03-17$36.15 (+0.56%)
02:11PMDaily Pharma Scoop Timing Synergy Trade Valeants Vyzulta Approved Seattle Genetics Files Sbla Seekingalpha
10:45AMEmergent (EBS) Q3 Earnings Beat Estimates, Guidance Raised Zacks
08:52AMIderas Public Offering Stinks Silver Lining Seekingalpha
08:00AM3 Things Biotech Learn Today November 3 2017 Seekingalpha
Nov-02-17$35.95 (-0.69%)
08:18AMGlaxoSmithKline Wins FDA Approval to Develop 'Breakthrough' Blood Cancer Drug theStreet
07:01AMWall Street Breakfast Prepare Powell Fed Seekingalpha
04:41AMWorld's Largest Generic Drug Maker Seeks Tie Up With Producer of Chinese Viagra Bloomberg
Nov-01-17$36.2 (-0.63%)
06:45AMGlaxosmithkline Comparative Analysis Potential Takeover Targets Cash Flow Dividend Seekingalpha
Oct-31-17$36.43 (-0.71%)
03:51PMNovartis Buys French Radiopharmaceutical Company Zacks
Oct-30-17$36.69 (+1.27%)
12:10PMInterested Rare Disease Segment Put Ionis Pharmaceuticals Shopping List 2017 Seekingalpha
10:27AM2 Top Pharma Stocks on Sale This Week Fool
09:01AMForeign Stock Roundup: Novartis, Bayer, Glaxo, Total Beat on Earnings Zacks
Oct-27-17$36.23 (-1.01%)
07:50AMPharma Stock Roundup: Lilly Tops on All Fronts, Mixed Results from Bristol-Myers Zacks
Oct-26-17$36.6 (-4.16%)
03:16PMGlaxosmithkline Q3 2017 Bear Signals Seekingalpha
12:18PMHere's Why Idera Pharmaceuticals Plunged as Much as 35% Today Fool
12:04PMDaily Pharma Scoop Roches Investment Potential Sarepta Lifts Guidance Pfizer Restructuring Seekingalpha
11:31AMGlaxo (GSK) Q3 Earnings Beat, Revenues In Line, Shares Down Zacks
06:37AM5 Products You Didn't Know Were Made By Pfizer theStreet
06:28AMWall Street Breakfast Future Path Ecb Stimulus Seekingalpha
03:45AMMr Market Gives And T Investors 6 Percent Seekingalpha
03:39AMPfizer sets date for auction of consumer healthcare unit: Reuters MarketWatch
Oct-25-17$38.19 (-5.66%)
07:36PMWarren Prods AIG Non-SIFI Label, GSK Joins List of Pfizer Consumer Beaus -- ICYMI theStreet
03:30PMPfizer to Sell Consumer Healthcare Business Next Month theStreet
12:54PMGlaxoSmithKline stock plummets 6% after concerns about dividend risk MarketWatch
12:05PMDaily Pharma Scoop Soliris New Indication Gileads Nash Data Keeps Synergy Seekingalpha
11:34AMGlaxo's CEO Sees ‘Real Costs’ From Brexit, Pushes for Clarity Bloomberg
06:59AMWall Street Breakfast Stocks Poised Tick Higher Seekingalpha
06:53AMGlaxo (GSK) Q3 Earnings Surpass Estimates, Revenues In Line Zacks
Oct-24-17$40.48 (-0.34%)
09:00PMIonis Pharmaceuticals Tumbles on Biogen's Miss: Buy or Sell? Fool
02:00PMAmerica’s Crackdown on The Opioid Crisis Hits Tasmania’s Poppy Farmers Bloomberg
08:12AMDrug/Biotech Stocks Q3 Earnings on Oct 25: AMGN, GSK, VRTX Zacks
07:52AMShould You Buy GlaxoSmithKline (GSK) Ahead of Earnings? Zacks
Oct-23-17$40.62 (-0.54%)
05:16PMIs Celgene (CELG) Poised for a Beat This Earnings Season? Zacks
10:04AMBig Biotech Crispr Game Novartis Vertex Lead Pack Seekingalpha
09:23AMGlaxosmithkline Lands Big Win Shingles Vaccine Seekingalpha
09:03AMIs Gilead (GILD) Poised for a Beat This Earnings Season? Zacks
08:30AMForeign Stock Roundup SAP, Taiwan Semiconductor Earnings Impress, Ericsson Disappoints Zacks
Oct-20-17$40.84 (-0.63%)
03:18PMCytodyn Dresses Hiv Patients Ccr5 Halloween Mask Seekingalpha
10:00AM3 High-Yield Pharmaceutical Stocks Fool
09:55AMGlaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again? Zacks
Oct-19-17$41.1 (+0.22%)
08:00AMNovartis Reports Positive Results on Thrombocytopenia Drug Zacks
Oct-18-17$41.01 (+0.44%)
03:21PMWhat to Expect from Big Pharmas After J&J's Solid Q3 Results? Zacks
11:23AM16 61 Safer Dividend Healthcare Dogs October Seekingalpha
09:36AMHealthcare Dogfight Owens And Minor Edges Glaxosmithkline Top Broker Pick Gains October Seekingalpha
Oct-17-17$40.83 (-0.07%)
11:51AMDynavax Reports Good News Seekingalpha
08:15AMFDA Grants Priority Review for Exelixis' RCC Drug Cabomteyx Zacks
Oct-16-17$40.86 (-0.37%)
05:07PMGlaxo's Shingles Vaccine Shingrix Gets Approval in Canada Zacks
04:12PMRecords for Wall Street as Apple Gains Offset Healthcare Slide theStreet
11:21AMSanofi Upward Trajectory 2017 Seekingalpha
Oct-13-17$41.01 (-0.02%)
03:14PM5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings Zacks
12:00AMGlaxo Finds a Rich Vein to Mine With Supercomputers Bloomberg
Oct-12-17$41.02 (+0.39%)
04:00PMIs Xi a Threat to Foreign Businesses in China? Bloomberg
12:33PMWhy some think it's 'prime time' for Amazon to enter pharmacy market theStreet
Oct-11-17$40.86 (+0.2%)
01:40PMPfizer: Who Will Pay $14B for Advil? Barron's
09:22AMPfizer Considering Sale/Spin-Off of Consumer Healthcare Unit Zacks
Oct-10-17$40.78 (+0.44%)
10:23AMThis Year's Flu Season Could Be Devastating theStreet
Oct-09-17$40.6 (-0.02%)
04:05PMAgenus Loads Impressive New Pipeline Seekingalpha
04:59AMGlaxosmithklines New Self Injectable Formulation Benlysta Makes Sense Seekingalpha
09:00AM3 High-Yield Healthcare Stocks Fool
Oct-06-17$40.61 (-0.12%)
01:31PMBiogen Problems Strategy Make Avoid Seekingalpha
Oct-03-17$40.94 (+0.07%)
03:02PMGetting 6 Percent Kick Glaxosmithkline Investment Seekingalpha
09:07AM5 Percent Dividend Yield Portfolio Real Estate Value Diversification Sep 2017 Review Seekingalpha
Oct-02-17$40.91 (+1.31%)
03:49PMPortfolio Summary Brief Walk Current Positions Seekingalpha
05:19AMStarting Point Big Pharma Novartis Sanofi Clear Hurdles Seekingalpha
Sep-28-17$40.38 (-0.02%)
03:44PMGlaxosmithkline Get Ready Dividend Cut Pharma Giant Seekingalpha
Sep-27-17$40.39 (-0.05%)
10:21AMAxovant Excellent Short Opportunity Failed Alzheimers Results Seekingalpha
Sep-26-17$40.41 (-0.59%)
12:00PMVbi Vaccines Hepatitis B Vaccine Key Value Driver Seekingalpha
06:25AMDaily Pharma Scoop Alnylams Big Win Aradigm Nda Rating Exel Azn Japan Expansions Seekingalpha
Sep-25-17$40.65 (+0.17%)
12:04PMHurricane Lessons Seekingalpha
11:19AMAlnylam Sanofi Achieve Rnai First Seekingalpha
10:22PMJ And J Thoughts Sirukumab Problems Seekingalpha
Sep-20-17$40.18 (+0.65%)
01:01PMSafer Dividend Follower Favorites Rogues Led Capitala Finance Seekingalpha
11:31AMDaily Pharma Scoop Gerons Growth Potential Ipsens Xarmelo Approval Gsks Ellipta Approved Seekingalpha
Sep-19-17$39.92 (-0.32%)
10:03AMMylan Time Sell Seekingalpha
Sep-15-17$40.24 (-0.27%)
10:17AMEpizyme Striding Epigenetic Breakthroughs Seekingalpha
Sep-14-17$40.35 (+0.62%)
03:21PMAxovant Sciences Progressively Contentious Alzheimers Claim Seekingalpha
08:06AMRisk Tolerant Healthcare Investors Look Pharmaceutical Stocks Dividend Income Seekingalpha
Sep-12-17$40.37 (+0.25%)
08:29AMDynavax Charts Path Forward Seekingalpha
08:00AM3 Things Biotech Learn Today September 12 2017 Seekingalpha
04:31AM3 Dividend Superstars Strong Growth Potential Glaxosmithkline Pfizer Sanofi Seekingalpha
Sep-11-17$40.27 (+0.55%)
05:31PMBig Pharma Duet Greets Reit Atop Safer Dividend Healthcare Pack Gains September Seekingalpha
04:30AMHealthcare Sector Glaxosmithkline Remains Top Broker Pick Gains September Seekingalpha
Aug-30-17$39.74 (+1.07%)
08:53AMJTA: Nifty Little Fund Seekingalpha
Aug-29-17$39.32 (-0.35%)
08:56PMGlaxoSmithKline Dividends Look More Attractive With New Management At The Helm Seekingalpha
Aug-28-17$39.46 (-0.03%)
09:48AMAxovant Sciences: The Contentious Alzheimer's Claim Seekingalpha
07:51AMNovartis AG: The Reliable European Healthcare Stock Seekingalpha
08:56AMWeek In Review: Columbia China Building $150 Million Hospital In Jiaxing Seekingalpha
Aug-24-17$39.46 (+0.36%)
12:14AMDiagnosing Merck (Part 2 Of 2) Seekingalpha
Aug-22-17$39.13 (+1.16%)
05:13PMLigand: Situated For Growth Seekingalpha
08:00AMShire: At 52-Week Low, Long-Term Opportunity Appears Significant Seekingalpha
Aug-18-17$38.75 (-0.77%)
01:53PMSnippet Roundup: Transparency For Straumann But A Black Box For Pfizer Seekingalpha
Aug-17-17$39.05 (-0.48%)
09:36AM'Safer' Dividend Follower Favorites & Rogues Led By RAIT Financial & Chico, Per August Gain... Seekingalpha
Aug-16-17$39.24 (+0.74%)
12:12PMBiogen's Alzheimer's Hope Tops The Sector's Most Valuable Pipeline Projects Seekingalpha
Aug-15-17$38.95 (-0.15%)
10:54AMBristol-Myers Squibb: HIV Franchise Was Never A Big Part Of The Game Plan Seekingalpha
Aug-14-17$39.01 (+0.57%)
11:56PMGilead's Newer Tenofovir Patents Might Aid Its HIV Franchise Seekingalpha
08:58AMIonis Absorbs Glaxo Rare Disease Cull Seekingalpha
07:51AM3 Things In Biotech You Should Learn Today: August 14, 2017 Seekingalpha
09:00AM3 Things In Biotech You Should Learn Today: August 13, 2017 Seekingalpha
Aug-09-17$39.53 (-1.54%)
08:22PMGlaxoSmithKline Is Broker Pick As Top Dog For Healthcare Sector Gains In August Seekingalpha
03:16AMTracking Kahn Brothers Portfolio - Q2 2017 Update Seekingalpha
Aug-07-17$40.3 (-0.57%)
09:30AMBiotech Forum Daily Digest: Revisiting Neurocrine Biosciences Seekingalpha
08:20AMRetired And Looking For More Dividend Income? The Top 10 International Dividend Stocks Seekingalpha
08:36AMWeek In Review: China VC/PE Funds Raising Capital At $30 Billion Rate In 2017 Seekingalpha
Aug-04-17$40.53 (-0.39%)
03:20AMLanny's July Dividend Income Summary Seekingalpha
Aug-02-17$40.75 (+0.34%)
09:41AMPharma Tightens Its Belt On Jobs As Markets Fall Seekingalpha
08:48AMAgenus Restructures Seekingalpha
07:51AMGlaxoSmithKline Rearranges, Once More Seekingalpha
Aug-01-17$40.61 (+0.22%)
07:51PMFear, Uncertainty, And Doubt - Managing Your FUD Factor Seekingalpha
09:53AMIs Amarin A Good Catch? Seekingalpha
Jul-31-17$40.52 (-1%)
02:44PMOpinions Split On Ox40 Seekingalpha
11:05AMSnippet Roundup: Approval For Spectranetics, Soon To Be Philips, But Meso Misses For Bayer Seekingalpha
Jul-28-17$40.93 (+0.44%)
01:06PMAn Upcoming Discussion With A Cardiologist On Amarin's Vascepa And Its Potential In Treatin... Seekingalpha
08:46AMGlaxoSmithKline: Doing An AstraZeneca (And A Reckitt Benckiser)? Seekingalpha
Jul-27-17$40.75 (-0.24%)
04:24PMDynavax: Looking Ahead To A Long and Tiring Journey Seekingalpha
03:52PMGlaxo Runs Into Double Trouble In HIV Seekingalpha
Jul-26-17$40.85 (-2.65%)
03:11PMGlaxo Gets Out The Axe Seekingalpha
Jul-25-17$41.96 (-0.66%)
10:10AMGilead Puts Up The Good Fight Once Again Seekingalpha
Jul-24-17$42.24 (-0.98%)
09:00AM3 Things In Biotech You Should Learn Today: July 24, 2017 Seekingalpha
Jul-21-17$42.66 (-0.26%)
10:32AMUnited Therapeutics Losing The Crown Jewels; 20% EPS Downgrades Ahead Seekingalpha
10:18AMSirukumab's Panel And U.S. Decision For Medicines Company Seekingalpha
Jul-19-17$42.42 (-0.02%)
08:57AMNovartis, Glaxo and Lilly Bigly Back New Biotech Barron's
Jul-18-17$42.43 (+0.4%)
12:08PM2017 - 2nd Quarter Portfolio Review - Continuing The Work Seekingalpha
Jul-17-17$42.26 (-1.15%)
09:00AM3 Things In Biotech You Should Learn Today: July 17, 2017 Seekingalpha
Jul-14-17$42.75 (+0.59%)
01:32PMFastest-Growing U.S. Drug Spender Medicaid In Danger Of Cuts Seekingalpha
Jul-13-17$42.5 (-0.05%)
02:50PMCytRx: SCLC Study Still Breathing? Seekingalpha
01:06PMQ3 Biotech Catalyst Watch: Key PDUFAs (Part 3) Seekingalpha
10:17AMBiotech Forum Daily Digest - New Leadership At Teva. A Trading Idea For Agenus. Seekingalpha
Jul-12-17$42.52 (+1.21%)
10:53AMClimate Change Investing: Momentum Building, Trump Notwithstanding Seekingalpha
Jul-07-17$42.26 (+0%)
10:36AMSnippet Roundup: Oxford Jumps On Novartis' CAR-T And EU Regulators Think For Themselves Seekingalpha
11:52PM'Safer' Dividend Big-Gain Healthcare Dog Leads 3 Big Pharma Names In June Seekingalpha
05:06AMHealthcare Has GlaxoSmithKline As Top Dog By Gains In June Seekingalpha
Jun-30-17$43.12 (-0.32%)
09:14AMThese Two Biotech Stocks Could Move On Near Term Vaccine Catalysts Seekingalpha
Jun-29-17$43.26 (-1.01%)
03:51PMThe Stem Cell Revolution Seekingalpha
Jun-27-17$43.91 (-0.36%)
04:36PMTiGenix: This Stem Cell Pioneer Is Up 40% Since IPO With More Upside To Come Seekingalpha
12:42PMCAR-T Value Calculation In The Firing Line Seekingalpha
02:34PMGlaxoSmithKline: 3 Reasons You Should Be Concerned Seekingalpha
11:02AMWeek In Review: Shenzhen's BGI Plans $250 Million China IPO To Support Genomics Operations Seekingalpha
Jun-22-17$44.16 (+1.24%)
10:13AMGilead: The Conundrum Seekingalpha
07:56AMOnly Bristol Bucks Big Pharma's Drive For External Reliance Seekingalpha
May-16-17$43.42 (+0.07%)
03:28PMGilead Needs To Best Glaxo With Bictegravir Seekingalpha
12:13PM3 Things In Biotech You Should Learn Today: May 16, 2017 Seekingalpha
09:14AMEWU Will Continue Its Rally Seekingalpha
May-15-17$43.39 (+0.3%)
02:23PMInvestors Scent Blood After Death In Ionis Trial Seekingalpha
May-10-17$42.28 (+0.83%)
11:10AMBristol-Myers Squibb: A Deep Dive Finds Some Pearls Seekingalpha
May-09-17$41.93 (+0.55%)
09:23AMBert's April Dividend Income Summary Seekingalpha
05:13AMTracking Kahn Brothers Portfolio - Q1 2017 Update Seekingalpha
May-05-17$41.78 (+0.07%)
11:54AMGlaxoSmithKline Pipeline Analysis: Robust Or Going Bust? Seekingalpha
May-03-17$41.16 (-0.63%)
12:24PM3 Things In Biotech You Should Learn Today: May 3, 2017 Seekingalpha
May-02-17$41.42 (+1.45%)
04:14PMEpizyme: Why Is Big Pharma Interested In This Small Biotech? Seekingalpha
May-01-17$40.83 (-0.17%)
05:02PMBiohaven Pharmaceuticals Seeks $125 Million IPO Seekingalpha
11:41AMMorningstar: This Large Biotech Could Be The World's Best Stock Seekingalpha
Apr-27-17$40.78 (+0.25%)
12:33PMGlaxoSmithKline Q1 2017: Mixed Signals For Investors Seekingalpha
Apr-26-17$40.68 (-1.93%)
02:40PMGlaxoSmithKline: Good News, 2016's Positive Momentum Continues Seekingalpha
12:27AM1st Quarter Portfolio Results - Better Than Expected Seekingalpha
Apr-21-17$40.78 (+0.17%)
03:19PMTeva Twin-Tracks Advair Competitor's Launch Seekingalpha
08:13AMMerck Leads Rivals In Novel Drug Approvals Seekingalpha
Apr-20-17$40.71 (-0.32%)
04:51AMWhat To Expect At GlaxoSmithKline's Q1/2017 Results Seekingalpha
Apr-18-17$41.28 (-1.34%)
07:21PMHealthcare Dogs See Medical Care Tops By Yield But Big Pharma Tops By Gains For April Seekingalpha
Apr-12-17$41.86 (+0.19%)
10:30AMMotif Bio: Way Too Risky Seekingalpha
Apr-10-17$41.3 (-0.41%)
01:42PMNovavax Will Ride High On RSV Vaccine Wave In 2017 Seekingalpha
09:18AMIs Ionis Pharmaceuticals Ready To Pop? Seekingalpha
Apr-07-17$41.47 (+0.12%)
04:45AMGlaxoSmithKline: A High Yield, But A Lot Of Risks To Consider Seekingalpha
07:00PMEuropean Stocks Euphoria Is Running High ... Maybe Too High theStreet
07:00PMEuropean Stocks Euphoria Is Running High ... Maybe Too High theStreet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat